Eisai
4523.T
#2267
Rank
C$12.24 B
Marketcap
C$43.40
Share price
0.32%
Change (1 day)
3.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.21. In 2026 the company made an earnings per share (EPS) of C$1.20 a decrease over its 2025 EPS that were of C$1.52.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.20-21.04%
2025C$1.5211.85%
2024C$1.36-32.63%
2023C$2.025.52%
2022C$1.91-74.01%
2021C$7.36-66.58%
2020C$22.0298.24%
2019C$11.1117.01%
2018C$9.4937.78%
2017C$6.89-27.62%
2016C$9.5235.33%
2015C$7.03-2.82%
2014C$7.24-27.66%
2013C$10.00-27.49%
2012C$13.80-12.67%
2011C$15.8088.08%
2010C$8.40-11.06%
2009C$9.45-390.15%
2008C-$3.26-127.78%
2007C$11.72347.11%
2006C$2.624.38%
2005C$2.517.4%
2004C$2.3443.03%
2003C$1.6425.09%
2002C$1.3152.67%
2001C$0.8669.76%
2000C$0.50